DK261384A - Renset hematoporphyrinderivat til diagnose og behandling af tumorer - Google Patents

Renset hematoporphyrinderivat til diagnose og behandling af tumorer Download PDF

Info

Publication number
DK261384A
DK261384A DK261384A DK261384A DK261384A DK 261384 A DK261384 A DK 261384A DK 261384 A DK261384 A DK 261384A DK 261384 A DK261384 A DK 261384A DK 261384 A DK261384 A DK 261384A
Authority
DK
Denmark
Prior art keywords
substance
molecular weight
tumours
haematoporthyrin
hematoporphyrine
Prior art date
Application number
DK261384A
Other languages
English (en)
Other versions
DK172284B1 (da
DK261384D0 (da
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Photofrin Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photofrin Medical Inc filed Critical Photofrin Medical Inc
Publication of DK261384A publication Critical patent/DK261384A/da
Publication of DK261384D0 publication Critical patent/DK261384D0/da
Application granted granted Critical
Publication of DK172284B1 publication Critical patent/DK172284B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK261384A 1982-09-27 1984-05-25 Renset hematoporfyrinderivat til diagnose og behandling af tumorer samt fremgangsmåde til fremstilling af de rensede derivater og præparater indeholdende dem DK172284B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US42464782 1982-09-27
US48134583A 1983-04-01 1983-04-01
US48134583 1983-04-01
US8301379 1983-09-09
PCT/US1983/001379 WO1984001382A1 (en) 1982-09-27 1983-09-09 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method

Publications (3)

Publication Number Publication Date
DK261384A true DK261384A (da) 1984-05-25
DK261384D0 DK261384D0 (da) 1984-05-25
DK172284B1 DK172284B1 (da) 1998-02-23

Family

ID=27026406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK261384A DK172284B1 (da) 1982-09-27 1984-05-25 Renset hematoporfyrinderivat til diagnose og behandling af tumorer samt fremgangsmåde til fremstilling af de rensede derivater og præparater indeholdende dem

Country Status (10)

Country Link
EP (1) EP0120054B1 (da)
JP (1) JPS60500132A (da)
AT (1) ATE53204T1 (da)
AU (1) AU581840B2 (da)
CA (1) CA1271746A (da)
DE (1) DE3381616D1 (da)
DK (1) DK172284B1 (da)
NL (1) NL940021I2 (da)
NO (1) NO166284C (da)
WO (1) WO1984001382A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
JPH0764728B2 (ja) * 1985-04-30 1995-07-12 日本石油化学株式会社 新規なテトラピロ−ル医薬用組成物
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
ATE87826T1 (de) * 1986-01-02 1993-04-15 Univ Toledo Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
GB2254417A (en) * 1991-04-05 1992-10-07 Bijan Jouza Photodynamic laser detection for cancer diagnosis
NL9200143A (nl) * 1992-01-27 1993-08-16 Seehof Lab F & E Ges Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling.
RU2128993C1 (ru) * 1996-03-27 1999-04-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Фармакологическое средство фотогем для фотодинамической терапии рака
US5948061A (en) 1996-10-29 1999-09-07 Double Click, Inc. Method of delivery, targeting, and measuring advertising over networks
US7039599B2 (en) 1997-06-16 2006-05-02 Doubleclick Inc. Method and apparatus for automatic placement of advertising
JP5053483B2 (ja) 1998-08-03 2012-10-17 グーグル インコーポレイティド 再ターゲット化広告配布のためのネットワーク
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
EP1517684B1 (en) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives

Also Published As

Publication number Publication date
NO166284C (no) 1991-06-26
DK172284B1 (da) 1998-02-23
AU581840B2 (en) 1989-03-09
EP0120054B1 (en) 1990-05-30
WO1984001382A1 (en) 1984-04-12
NO166284B (no) 1991-03-18
NL940021I1 (nl) 1997-03-03
JPS60500132A (ja) 1985-01-31
AU2032283A (en) 1984-04-24
NL940021I2 (nl) 1997-05-01
DK261384D0 (da) 1984-05-25
ATE53204T1 (de) 1990-06-15
EP0120054A1 (en) 1984-10-03
NO842089L (no) 1984-05-25
EP0120054A4 (en) 1985-04-11
DE3381616D1 (de) 1990-07-05
CA1271746A (en) 1990-07-17

Similar Documents

Publication Publication Date Title
DK261384A (da) Renset hematoporphyrinderivat til diagnose og behandling af tumorer
PT77125A (en) Process for preparing triphenylimidazolyloxy-alkanoic acids and their derivatives and of pharmaceutical compositions containing these compounds
ATE1192T1 (de) Verfahren zur herstellung von beta-lactam-derivaten, die so erhaltenen neuen derivate sowie diese derivate enthaltende pharmazeutische zusammensetzungen.
BE847153A (fr) Procede de preparation d'acide formique pur,
ES388527A1 (es) Procedimiento para la preparacion de dipropilacetato de calcio destinado a aumentar el nivel sanguineo de calcio y afavorecer la recalcificacion en el organismo humano y ani- mal.
ES2028004T3 (es) Procedimiento para la recuperacion del rodio de las soluciones acuosas que contienen unas combinaciones complejas del rodio.
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
Slocum et al. The preparation of several N-Substituted and N, N-Disubstituted ferrocenesulfonamides
JPS54160334A (en) Separation of 33and 44nitrophthalic acid mixture
FR2437405A1 (fr) Nouveaux alcoylbenzenes substitues basiques utiles comme medicaments
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ATE85605T1 (de) Verfahren zur herstellung von trans-1,1,2triphenyl -but-1-en derivaten.
CH611602A5 (en) Process for the preparation of (N-ethyl-2-pyrrolidino)methylamine derivatives
Fulton The constitution of photostilbamidine, the irradiation product of stilbamidine
ES544859A0 (es) Un procedimiento para preparar 1-imidazolilmetilestirenos
JPS5795918A (en) Purification of immunoglobulin
SU427699A1 (ru) Способ диагностики эндометритов у коров
Stevens et al. Studies on Acid Hydrolysates of Vesicant-treated Insulin1
JPS5214721A (en) Process for preparation of sodium malate hydrate
DK632187D0 (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
Feuer et al. Preparation and Reactions of α, α'-Dibromo-α, α'-dinitrocyclic Ketones1
SU785293A1 (ru) Способ получени дифенил-2,2 ,6,6тетраальдегида
JPS6251658A (ja) カルボキシメチルシステインのラセミ化法
FR2603286A1 (fr) Procede de preparation de derives de l'acide phosphineux et produit intermediaire utilise a cet effet
JPS556247A (en) Abnormal range administrating blood serum for thymol kunckel

Legal Events

Date Code Title Description
PUP Patent expired
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2000 00012

Filing date: 20000517

Expiry date: 20080909